BELL vs. SUN, DEMG, NIOX, SN, MXCT, EKF, CREO, IUG, NCYT, and IHC
Should you be buying Belluscura stock or one of its competitors? The main competitors of Belluscura include Surgical Innovations Group (SUN), Deltex Medical Group (DEMG), NIOX Group (NIOX), Smith & Nephew (SN), MaxCyte (MXCT), EKF Diagnostics (EKF), Creo Medical Group (CREO), Intelligent Ultrasound Group (IUG), Novacyt (NCYT), and Inspiration Healthcare Group (IHC). These companies are all part of the "medical devices" industry.
Belluscura vs.
Surgical Innovations Group (LON:SUN) and Belluscura (LON:BELL) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, earnings, valuation, media sentiment, risk, analyst recommendations, profitability, institutional ownership and community ranking.
Surgical Innovations Group has higher revenue and earnings than Belluscura.
Surgical Innovations Group has a net margin of -4.96% compared to Belluscura's net margin of -1,030.73%. Surgical Innovations Group's return on equity of -6.04% beat Belluscura's return on equity.
25.8% of Surgical Innovations Group shares are held by institutional investors. Comparatively, 6.3% of Belluscura shares are held by institutional investors. 67.2% of Surgical Innovations Group shares are held by insiders. Comparatively, 56.3% of Belluscura shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Surgical Innovations Group has a beta of 0.65, meaning that its stock price is 35% less volatile than the S&P 500. Comparatively, Belluscura has a beta of 1.05, meaning that its stock price is 5% more volatile than the S&P 500.
Surgical Innovations Group received 121 more outperform votes than Belluscura when rated by MarketBeat users.
In the previous week, Surgical Innovations Group had 1 more articles in the media than Belluscura. MarketBeat recorded 1 mentions for Surgical Innovations Group and 0 mentions for Belluscura. Belluscura's average media sentiment score of 0.00 beat Surgical Innovations Group's score of -0.10 indicating that Belluscura is being referred to more favorably in the news media.
Summary
Surgical Innovations Group beats Belluscura on 8 of the 12 factors compared between the two stocks.
Get Belluscura News Delivered to You Automatically
Sign up to receive the latest news and ratings for BELL and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Belluscura Competitors List
Related Companies and Tools
This page (LON:BELL) was last updated on 5/2/2025 by MarketBeat.com Staff
Buy BELL Stock Free BELL Stock Alerts